Vida Ventures Advisors
BOSTON, MAfiles as Vida Ventures Advisors, LLC
$29m in 2 US stocks at the end of 30 September 2025. The top 10 are 100.0% of the money. It changed about 5.2% of the portfolio this quarter.
Value
$29m
Stocks
2
Top 10 share
100.0%
Turnover
5.2%
What changed this quarter
New
Bought for the first time this quarter.
None this quarter.
Added
Bought more of a stock they already held.
None this quarter.
Cut
Sold some of their stake.
None this quarter.
Sold out
Sold their entire stake.
None this quarter.
Holdings
| Company | Share of fund | Value | Shares | Change |
|---|---|---|---|---|
| Kyverna TherapeuticsKYTX | 92.4% | $27m | 4,523,924 | Held |
| Allogene TherapeuticsALLO | 7.6% | $2m | 1,798,163 | Held |
Over time and by industry
Value over time
Sep '25
Value is up 84.5% since 30 June 2025.
Where the money is
Health care100.0%
From the fund's 13F filings. They list US stocks and options only, 45 days after each quarter, and leave out cash, bonds, shorts and foreign shares.